Companies / Tridek-One
Tridek-One
Company
Tridek-One develops first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases
Tridek-One has 4 investors on file, among them AdBio partners, Advent Life Sciences and Bioqube Ventures. Its site turns away automated reads, so VCinfo could not check it; it is listed because an investor's own portfolio page links to it.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Tridek-One and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when AdBio partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/tridekone.com/investors
# also
GET /v1/companies/tridekone.com
GET /v1/companies/tridekone.com/news